CDC/NIOSH Update 2022.02

Don Lawson -

MILT Update 4013 added a new feature that looks for the generic names of medications from the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 in text fields. When found, MILT alerts the user that they might be working with a hazardous medication and recommends caution. This feature is provided for informational purposes only. It is not provided as, or intended to be, a substitute for expert pharmacological knowledge.

We planned to update the source list in MILT when the CDC published a new document, but unfortunately, the review and publication of the next document has been delayed for some time now.

To satisfy several requests, an interim update for MILT has been published with the following changes to the original list:

trabectedin (Yondelis®) 
inotuzumab ozogamicin (Besponsa™) 
polatuzumab vedotin (Polivy™) 
enfortumab vedotin (Padcev™) 
trastuzumab deruxtecan (Enhertu®) 
sacituzumab govitecan (Trodelvy™) 
Loncastuximab tesirine (Zynlonta™) 
melphalan flufenamide (Pepaxto®) 
belantamab mafodotin (Blenrep) 

risperidone (Risperidal®)
paliperidone (Invega®)
telavancin (VIBATIV®) 



From a computer with MILT installed, download and run 

The update will display the path to your active database file. Click the Update Button to complete the process.


- A backup of your database is performed automatically when you start the update

- Large network database may take one minute or more to update

- The update occurs in the database. All MILT computers that use this database will all be updated when one completes this process.

- If the update fails please call 800.523.8966 to resolve any issues.

Have more questions? Submit a request
Powered by Zendesk